Published online Jun 14, 2016. doi: 10.3748/wjg.v22.i22.5211
Peer-review started: December 22, 2015
First decision: January 13, 2016
Revised: March 1, 2016
Accepted: March 18, 2016
Article in press: March 1, 2016
Published online: June 14, 2016
Processing time: 163 Days and 21.7 Hours
AIM: To evaluate gut microbial dysbiosis in two visceral hypersensitive models in comparison with irritable bowel syndrome (IBS) patients and to explore the extent to which these models capture the dysbiosis of IBS patients.
METHODS: Visceral hypersensitivity was developed using the maternal separation (MS) rat model and post-inflammatory rat model. The visceral sensitivity of the model groups and control group was evaluated using the abdominal withdraw reflex score and electromyography in response to graded colorectal distention. The 16S ribosomal RNA gene from fecal samples was pyrosequenced and analyzed. The correlation between dysbiosis in the microbiota and visceral hypersensitivity was calculated. Positive findings were compared to sequencing data from a published human IBS cohort.
RESULTS: Dysbiosis triggered by neonatal maternal separation was lasting but not static. Both MS and post-inflammatory rat fecal microbiota deviated from that of the control rats to an extent that was larger than the co-housing effect. Two short chain fatty acid producing genera, Fusobacterium and Clostridium XI, were shared by the human IBS cohort and by the maternal separation rats and post-inflammatory rats, respectively, to different extents. Fusobacterium was significantly increased in the MS group, and its abundance positively correlated with the degree of visceral hypersensitivity. Porphyromonadaceae was a protective biomarker for both the rat control group and healthy human controls.
CONCLUSION: The dysbiosis MS rat model and the post-inflammatory rat model captured some of the dysbiosis features of IBS patients. Fusobacterium, Clostridium XI and Porphyromonadaceae were identified as targets for future mechanistic research.
Core tip: Dysbiosis of the gastrointestinal microbiota and hypersensitivity to colonic distension are critical features of irritable bowel syndrome (IBS). For animal models, the correlation between dysbiosis in the microbiota and visceral hypersensitivity remains unknown. This study identified common biomarkers between the animal models and IBS patients, which may be targets for future mechanistic research.